HIV infection and atherosclerosis

Evaluating the drivers of inflammation

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

As the population of people living with HIV ages, atherosclerotic cardiovascular disease (ASCVD) has become an increasing cause of morbidity and mortality. Traditional cardiovascular risk factors are common among those with HIV. In addition, some antiretroviral therapy (ART) regimens contribute to conditions such as hyperlipidemia and insulin resistance. However, inflammation is increasingly recognized as a key contributor to ASCVD. HIV infection induces immune activation and inflammation through several mechanisms. Co-infections such as hepatitis C and cytomegalovirus along with HIV itself likely initiate immune activation and inflammation. Translocation of bacterial products across a compromised epithelial barrier as a result of HIV infection is another mechanism by which the immune system is activated. In this article we summarize the current understanding of drivers of immune activation and inflammation among those with HIV and the contribution of each to ASCVD.

Original languageEnglish (US)
Pages (from-to)720-728
Number of pages9
JournalEuropean Journal of Preventive Cardiology
Volume20
Issue number5
DOIs
StatePublished - Oct 2013

Fingerprint

HIV Infections
Atherosclerosis
HIV
Inflammation
Cardiovascular Diseases
Bacterial Translocation
Hepatitis C
Hyperlipidemias
Cytomegalovirus
Coinfection
Insulin Resistance
Immune System
Morbidity
Mortality
Population
Therapeutics

Keywords

  • atherosclerosis
  • cytomegalovirus
  • hepatitis C
  • HIV
  • inflammation
  • microbial translocation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Epidemiology

Cite this

@article{9a5937db1585474aa07468c5db97cbbf,
title = "HIV infection and atherosclerosis: Evaluating the drivers of inflammation",
abstract = "As the population of people living with HIV ages, atherosclerotic cardiovascular disease (ASCVD) has become an increasing cause of morbidity and mortality. Traditional cardiovascular risk factors are common among those with HIV. In addition, some antiretroviral therapy (ART) regimens contribute to conditions such as hyperlipidemia and insulin resistance. However, inflammation is increasingly recognized as a key contributor to ASCVD. HIV infection induces immune activation and inflammation through several mechanisms. Co-infections such as hepatitis C and cytomegalovirus along with HIV itself likely initiate immune activation and inflammation. Translocation of bacterial products across a compromised epithelial barrier as a result of HIV infection is another mechanism by which the immune system is activated. In this article we summarize the current understanding of drivers of immune activation and inflammation among those with HIV and the contribution of each to ASCVD.",
keywords = "atherosclerosis, cytomegalovirus, hepatitis C, HIV, inflammation, microbial translocation",
author = "Archana Maniar and Collin Ellis and David Asmuth and Pollard, {Richard B} and Rutledge, {John C}",
year = "2013",
month = "10",
doi = "10.1177/2047487312447843",
language = "English (US)",
volume = "20",
pages = "720--728",
journal = "European Journal of Preventive Cardiology",
issn = "2047-4873",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - HIV infection and atherosclerosis

T2 - Evaluating the drivers of inflammation

AU - Maniar, Archana

AU - Ellis, Collin

AU - Asmuth, David

AU - Pollard, Richard B

AU - Rutledge, John C

PY - 2013/10

Y1 - 2013/10

N2 - As the population of people living with HIV ages, atherosclerotic cardiovascular disease (ASCVD) has become an increasing cause of morbidity and mortality. Traditional cardiovascular risk factors are common among those with HIV. In addition, some antiretroviral therapy (ART) regimens contribute to conditions such as hyperlipidemia and insulin resistance. However, inflammation is increasingly recognized as a key contributor to ASCVD. HIV infection induces immune activation and inflammation through several mechanisms. Co-infections such as hepatitis C and cytomegalovirus along with HIV itself likely initiate immune activation and inflammation. Translocation of bacterial products across a compromised epithelial barrier as a result of HIV infection is another mechanism by which the immune system is activated. In this article we summarize the current understanding of drivers of immune activation and inflammation among those with HIV and the contribution of each to ASCVD.

AB - As the population of people living with HIV ages, atherosclerotic cardiovascular disease (ASCVD) has become an increasing cause of morbidity and mortality. Traditional cardiovascular risk factors are common among those with HIV. In addition, some antiretroviral therapy (ART) regimens contribute to conditions such as hyperlipidemia and insulin resistance. However, inflammation is increasingly recognized as a key contributor to ASCVD. HIV infection induces immune activation and inflammation through several mechanisms. Co-infections such as hepatitis C and cytomegalovirus along with HIV itself likely initiate immune activation and inflammation. Translocation of bacterial products across a compromised epithelial barrier as a result of HIV infection is another mechanism by which the immune system is activated. In this article we summarize the current understanding of drivers of immune activation and inflammation among those with HIV and the contribution of each to ASCVD.

KW - atherosclerosis

KW - cytomegalovirus

KW - hepatitis C

KW - HIV

KW - inflammation

KW - microbial translocation

UR - http://www.scopus.com/inward/record.url?scp=84884143789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884143789&partnerID=8YFLogxK

U2 - 10.1177/2047487312447843

DO - 10.1177/2047487312447843

M3 - Article

VL - 20

SP - 720

EP - 728

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

SN - 2047-4873

IS - 5

ER -